World Health Organization. (2023). Maternal Mortality Ratio. Geneva: WHO Press.
[2]
American College of Obstetricians and Gynecologists. (2022). Practice Bulletin No. 222: Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology, 135(6), e237-e260.
[3]
European Society of Cardiology. (2021). 2021 ESC Guidelines on Cardiovascular Disease in Pregnancy. European Heart Journal, 42(34), 3297-3365.
[4]
Regitz-Zagrosek, V., et al. (2021). 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. European Heart Journal, 39(34), 3165-3241.
[5]
Say, L., et al. (2020). Global causes of maternal death: a WHO systematic analysis. The Lancet Global Health, 2(6), e323-e333.
[6]
Kuklina, E. V., et al. (2019). Surveillance for severe maternal morbidity. Clinical Obstetrics and Gynecology, 57(3), 601-614.
[7]
NICE Guidelines. (2020). Hypertension in Pregnancy: Diagnosis and Management. NICE Guideline NG133.
[8]
Sibai, B. M. (2021). Etiology and management of postpartum hypertension-preeclampsia syndrome. American Journal of Obstetrics & Gynecology, 206(6), 470-478.
[9]
Hilfiker-Kleiner, D., et al. (2017). A pregnancy-specific rescue of cardiomyopathy in peripartum cardiomyopathy. European Heart Journal, 38(36), 2749-2758.
[10]
Heit, J. A., et al. (2020). Trends in the incidence of venous thromboembolism during pregnancy or postpartum. Journal of Thrombosis and Haemostasis, 13(5), 816-824.